日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer

非小细胞肺癌患者在接受皮质类固醇和二线免疫抑制剂治疗后出现免疫相关不良事件时,检查点抑制剂的疗效

van Dijk, E J; Smeenk, M M; Bensch, F; Sadowska, A M; Verschueren, M V; Verhaert, M; Llobell, A; Suzuki, Y; Liew, D F L; Takeji, A; Maria, A T J; Peters, B J M; Garcia Morillo, J S; Chatzidionysiou, K; Lidar, M; van der Hout, E C; Aspeslagh, S; Herder, G J M; van de Garde, E M W; Hendriks, L E L; Hijmering-Kappelle, L B M; Theelen, W S M E; Suijkerbuijk, K P M; Verheijden, R J

Development and validation of the Klinefelter-Associated Neurodevelopmental Difficulties (KAND) Checklist: a three-phase mixed-methods study

克氏综合征相关神经发育困难(KAND)检查表的开发与验证:一项三阶段混合方法研究

Theelen, Kaat; Galasso, Costantino; Cools, Wilfried; Gies, Inge; Vanclooster, Stephanie; Jansen, Anna C

Model-Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness

基于模型的皮下注射纳武利尤单抗替代给药策略以提高成本效益

Wang, Yan; Bukkems, Laura H; Ter Heine, Rob; van Hasselt, J G C; Koolen, S L W; Hendrikx, J J M A; Van der Hulle, Tom; Kapiteijn, Ellen; Zwaveling, Juliette; Becker, Annemarie; van den Heuvel, Michel M; Theelen, Willemijn S M E; Oude Munnink, Thijs H; Smit, Egbert F; Guchelaar, Henk-Jan; Moes, Dirk Jan A R

Sequential measurement of serum amyloid A concentrations in ill hospitalized neonatal foals

对患病住院新生驹血清淀粉样蛋白A浓度进行连续测量

van den Brom-Spierenburg, Astrid J; Siegers, Esther W; Westermann, Cornélie M; Vernooij, Johannes C M; Sloet van Oldruitenborgh-Oosterbaan, Marianne M; Theelen, Mathijs J P

Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation

美国国家癌症研究所关于免疫疗法与放射疗法联合应用的研讨会论文集:临床转化的挑战与机遇

Morris, Zachary S; Demaria, Sandra; Monjazeb, Arta M; Formenti, Silvia C; Weichselbaum, Ralph R; Welsh, James; Enderling, Heiko; Schoenfeld, Jonathan D; Brody, Joshua D; McGee, Heather M; Mondini, Michele; Kent, Michael S; Young, Kristina H; Galluzzi, Lorenzo; Karam, Sana D; Theelen, Willemijn S M E; Chang, Joe Y; Huynh, Mai Anh; Daib, Adi; Pitroda, Sean; Chung, Caroline; Serre, Raphael; Grassberger, Clemens; Deng, Jie; Sodji, Quaovi H; Nguyen, Anthony T; Patel, Ravi B; Krebs, Simone; Kalbasi, Anusha; Kerr, Caroline; Vanpouille-Box, Claire; Vick, Logan; Aguilera, Todd A; Ong, Irene M; Herrera, Fernanda; Menon, Hari; Smart, DeeDee; Ahmed, Jalal; Gartrell, Robyn D; Roland, Christina L; Fekrmandi, Fatemeh; Chakraborty, Binita; Bent, Eric H; Berg, Tracy J; Hutson, Alan; Khleif, Samir; Sikora, Andrew G; Fong, Lawrence

Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study

在晚期非小细胞肺癌中,帕博利珠单抗混合给药方案不劣于固定剂量方案:一项真实世界回顾性双中心队列研究

Smeenk, Michiel M; van der Noort, Vincent; Hendrikx, Jeroen M A; Abedian Kalkhoran, Hanieh; Smit, Egbert F; Theelen, Willemijn S M E

Categorizing immunotherapy resistance mechanisms in non-small cell lung cancer: how can we perform better?

非小细胞肺癌免疫治疗耐药机制分类:我们如何才能做得更好?

van der Geest, Daphne; van Vliet, Alex; Peeper, Daniel S; Haanen, John B A G; Smit, Egbert F; Theelen, Willemijn S M E

Response to: Comment on 'Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study' by Zhu

回应:朱先生发表的题为“在晚期非小细胞肺癌中,帕博利珠单抗混合给药方案不劣于固定剂量方案:一项真实世界回顾性双中心队列研究”的评论

Smeenk, Michiel M; van der Noort, Vincent; Hendrikx, Jeroen J M A; Abedian Kalkhoran, Hanieh; Smit, Egbert F; Theelen, Willemijn S M E

Response to: Correspondence on 'Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer-a real-world, retrospective bicenter cohort study' by Wang

回复:王教授关于“帕博利珠单抗混合给药方案在晚期非小细胞肺癌治疗中不劣于固定剂量方案——一项真实世界回顾性双中心队列研究”的来信

Smeenk, Michiel M; van der Noort, Vincent; Hendrikx, Jeroen J M A; Abedian Kalkhoran, Hanieh; Smit, Egbert F; Theelen, Willemijn S M E

Tremelimumab plus Durvalumab prior to Chemoradiotherapy in Unresectable, Locally Advanced Non-Small Cell Lung Cancer: The Induction Trial

在不可切除的局部晚期非小细胞肺癌患者中,化疗放疗前使用曲美利单抗联合度伐利尤单抗:诱导试验

Smeenk, Michiel M; van Diessen, Judi N A; Boellaard, Thierry N; Hartemink, Koen J; de Vries, Jeltje F; van der Noort, Vincent; Badrising, Sushil K; Owers, Emilia C; Monkhorst, Kim; van den Heuvel, Michel M; Theelen, Willemijn S M E